Literature DB >> 7647218

Tissue factor antigen levels in various biological fluids.

J Fareed1, D D Callas, D Hoppensteadt, E W Bermes.   

Abstract

Tissue factor (TF), a transmembrane surface protein, is known to initiate thrombogenesis through plasmatic and cellular activation processes. Besides complexing with factor VII, eventually leading to fibrin generation via the extrinsic pathway, TF can also activate factor IX, resulting in the intrinsic activation of coagulation. Other functions of TF are currently unknown, although various cells are believed to have TF receptors. Many of the post-surgical and post-interventional thrombotic events are due to the release of TF. Increased levels of TF are associated with several pathologic conditions such as cancer, sepsis and inflammation. Cellular necrosis also results in an increase of TF as the cells in the traumatized area lyse and release endogenous cell surface-bound TF. An ELISA method (American Diagnostica, Greenwich, CT) has been developed to assay TF antigen levels in various biological fluids. This ELISA employs a murine monoclonal antibody raised against native human TF for antigen capture. In this study, cerebrospinal fluid, peritoneal fluid, pleural effusion and urine from patients were assayed for their TF content using this ELISA method. Normal individual serum and plasma were also assayed as controls against which the levels of TF in the patients' body fluids could be compared. The amount of TF antigen in normal human plasma and serum was 165 +/- 139 pg/ml and 165 +/- 110 pg/ml, respectively. Concentrations of TF antigen in other fluids were: cerebrospinal fluid 868 +/- 721 pg/ml, peritoneal fluid 124 +/- 247 pg/ml, pleural effusion 385 +/- 569 pg/ml, synovial fluid 97 +/- 23 pg/ml, seminal plasma 11,485 +/- 875 pg/ml and urine 86 +/- 57 pg/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647218     DOI: 10.1097/00001721-199506001-00006

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

Review 1.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Tissue factor-bearing microparticles and thrombus formation.

Authors:  Jeffrey I Zwicker; Cameron C Trenor; Barbara C Furie; Bruce Furie
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

3.  Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

Authors:  Junjiang Sun; Narine Hakobyan; Leonard A Valentino; Brian L Feldman; R Jude Samulski; Paul E Monahan
Journal:  Blood       Date:  2008-08-20       Impact factor: 22.113

4.  Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites.

Authors:  D Hariharan; E A Wilkes; G P Aithal; S J Travis; D N Lobo
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

5.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

6.  Procoagulant phospholipids and tissue factor activity in cerebrospinal fluid from patients with intracerebral haemorrhage.

Authors:  Patrick Van Dreden; Guy Hue; Jean-François Dreyfus; Barry Woodhams; Marc Vasse
Journal:  Adv Hematol       Date:  2014-02-17

7.  Salivary tissue factor induces thrombin generation in a diurnal rhythm.

Authors:  Lisa N van der Vorm; Joost E I G Brouwers; Ceráya Mondria; Bas de Laat; Philip G de Groot; Jasper A Remijn
Journal:  Res Pract Thromb Haemost       Date:  2018-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.